Home
Stocks
Cochlear Limited
Filings
Cochlear Limited (OTC:CHEOF) Filings
Cochlear Limited
Filings
Filing
Date
Type
Filed with
Appendix 3Y - Michael del Prado
Nov 17, 2026
Other filings
ASX
Appendix 3Y - Diggory Howitt
Nov 17, 2026
Other filings
ASX
Notification regarding unquoted securities - COH
Nov 17, 2026
Other filings
ASX
CMD details, CNA leader change & FY27 guidance reaffirmed
Nov 12, 2026
Guidance
ASX
2026 AGM Results
Oct 25, 2026
Other filings
ASX
2026 AGM Chair and CEO & President Addresses
Oct 25, 2026
Other filings
ASX
Ceasing to be a substantial holder
Oct 22, 2026
Ownership change notice
ASX
Notification of cessation of securities - COH
Oct 13, 2026
Financing
ASX
Notification regarding unquoted securities - COH
Oct 13, 2026
Other filings
ASX
Notification regarding unquoted securities - COH
Oct 13, 2026
Other filings
ASX
Ceasing to be a substantial holder
Oct 11, 2026
Ownership change notice
ASX
Change in substantial holding
Oct 5, 2026
Ownership change notice
ASX
Defence of Class Action Proceedings
Sep 28, 2026
Legal or regulatory action
ASX
Cochlear to host Capital Markets Day
Sep 24, 2026
Other filings
ASX
Notification regarding unquoted securities - COH
Sep 23, 2026
Other filings
ASX
Update - Dividend/Distribution - COH
Sep 22, 2026
Dividend
ASX
Notice of Annual General Meeting & Proxy/Voting Form
Sep 22, 2026
Meeting notice
ASX
Appointment of Prof. Ian Meredith to the Cochlear Board
Sep 17, 2026
Other filings
ASX
Change in substantial holding
Sep 17, 2026
Ownership change notice
ASX
Change in substantial holding
Sep 6, 2026
Ownership change notice
ASX
Ceasing to be a substantial holder
Sep 6, 2026
Ownership change notice
ASX
Ceasing to be a substantial holder
Sep 4, 2026
Ownership change notice
ASX
S&P DJI Announces September 2026 Quarterly Rebalance
Sep 4, 2026
Other filings
ASX
Ceasing to be a substantial holder
Sep 4, 2026
Ownership change notice
ASX
Change in substantial holding
Sep 3, 2026
Ownership change notice
ASX
Becoming a substantial holder
Sep 3, 2026
Ownership change notice
ASX
Appendix 3Y - Richard Freudenstein
Sep 2, 2026
Other filings
ASX
Becoming a substantial holder
Sep 2, 2026
Ownership change notice
ASX
Change in substantial holding
Sep 2, 2026
Ownership change notice
ASX
Change in substantial holding
Sep 1, 2026
Ownership change notice
ASX
Ceasing to be a substantial holder
Aug 28, 2026
Ownership change notice
ASX
Update - Notification of buy-back - COH
Aug 27, 2026
Treasury share status
ASX
Becoming a substantial holder
Aug 27, 2026
Ownership change notice
ASX
Appendix 3Y - Michael del Prado
Aug 26, 2026
Other filings
ASX
Appendix 3Y - Caroline Clarke
Aug 26, 2026
Other filings
ASX
Change in substantial holding
Aug 26, 2026
Ownership change notice
ASX
Change in substantial holding
Aug 26, 2026
Ownership change notice
ASX
Appendix 3Y - Michael Daniell
Aug 24, 2026
Other filings
ASX
Appendix 3Y - Alison Deans
Aug 24, 2026
Other filings
ASX
Appendix 3Y - Christine McLoughlin
Aug 24, 2026
Other filings
ASX
Appendix 3Y - Karen Penrose
Aug 24, 2026
Other filings
ASX
Appendix 3Y - Diggory Howitt
Aug 24, 2026
Other filings
ASX
Notification of cessation of securities - COH
Aug 24, 2026
Financing
ASX
FY26 Result - Presentation
Aug 17, 2026
Results
ASX
Appendix 4G
Aug 17, 2026
Other filings
ASX
FY26 Result - ASX & Media Release
Aug 17, 2026
Results
ASX
2026 Tax Contribution Report
Aug 17, 2026
ESG report
ASX
Dividend/Distribution - COH
Aug 17, 2026
Dividend
ASX
Annual Report
Aug 17, 2026
Annual report
ASX
Appendix 4E
Aug 17, 2026
Results
ASX
Date of AGM and closing date for director nominations
Aug 16, 2026
Meeting notice
ASX
Change in substantial holding
Aug 14, 2026
Ownership change notice
ASX
Change in substantial holding
Aug 13, 2026
Ownership change notice
ASX
Becoming a substantial holder
Aug 12, 2026
Ownership change notice
ASX
Ceasing to be a substantial holder
Aug 6, 2026
Ownership change notice
ASX
Becoming a substantial holder
Aug 4, 2026
Ownership change notice
ASX
Notice of FY26 result analyst and media briefing
Jul 28, 2026
Other filings
ASX
Becoming a substantial holder
Jul 27, 2026
Ownership change notice
ASX
Trading update and reduction to FY26 earnings guidance
Apr 21, 2026
Guidance
ASX
HY26 Result - Presentation Slides
Feb 12, 2026
Results
ASX
HY26 Result - ASX & Media Release
Feb 12, 2026
Other filings
ASX
Appendix 4D and Half Year Financial Report
Feb 12, 2026
Interim report
ASX
2025 AGM Chair and CEO & President Addresses
Oct 22, 2025
Other filings
ASX
Update - Notification of buy-back - COH
Aug 14, 2025
Treasury share status
ASX
FY25 Result - ASX & Media Release
Aug 14, 2025
Results
ASX
FY25 Result - Presentation
Aug 14, 2025
Results
ASX
Appendix 4E
Aug 14, 2025
Results
ASX
Cochlear provides update to FY25 earnings guidance
Jun 11, 2025
Guidance
ASX
Cochlear statement on US tariff announcement
Apr 8, 2025
Other filings
ASX
Cochlear awaits clarification on application of US tariff
Apr 2, 2025
Explanation request
ASX
HY25 Result - ASX & Media Release
Feb 13, 2025
Other filings
ASX
HY25 Result - Presentation Slides
Feb 13, 2025
Other filings
ASX
2024 AGM Chair and CEO & President Addresses
Oct 24, 2024
Other filings
ASX
FY24 Result - Presentation
Aug 14, 2024
Results
ASX
FY24 Result - ASX & Media Release
Aug 14, 2024
Results
ASX
Cochlear acquires Demant cochlear implant business
May 21, 2024
Acquisition or disposal
ASX
HY24 Result - Presentation Slides
Feb 18, 2024
Other filings
ASX
HY24 Result - ASX & Media Release
Feb 18, 2024
Results
ASX
Cochlear Upgrades FY24 Earnings Guidance
Feb 7, 2024
Guidance
ASX
2023 AGM Chair and CEO & President Addresses
Oct 16, 2023
Other filings
ASX
FY23 Result - Presentation
Aug 14, 2023
Other filings
ASX
FY23 Result - ASX & Media Release
Aug 14, 2023
Other filings
ASX
Oticon Medical Acquisition - UK CMA Final Report & Update
Jun 22, 2023
Acquisition or disposal
ASX
Provisional findings from the UK CMA
Apr 20, 2023
Other filings
ASX
HY23 Result - Presentation Slides
Feb 14, 2023
Other filings
ASX
HY23 Result - ASX & Media Release
Feb 14, 2023
Other filings
ASX
Oticon Medical acquisition - UK CMA decision
Dec 6, 2022
Acquisition or disposal
ASX
Acquisition of Oticon Medical-ACCC Statement
Nov 30, 2022
Acquisition or disposal
ASX
2022 AGM Chair and CEO & President Addresses
Oct 17, 2022
Other filings
ASX
FY22 Result Presentation
Aug 18, 2022
Other filings
ASX
FY22 Result - ASX & Media Release
Aug 18, 2022
Other filings
ASX
Cochlear agrees to acquire Oticon Medical
Apr 27, 2022
Acquisition or disposal
ASX
Half Year Results Presentation
Feb 21, 2022
Interim report
ASX
Half Year Results Announcement
Feb 21, 2022
Interim report
ASX
FY21 Result - ASX & Media Release
Aug 19, 2021
Other filings
ASX
Half Yearly Report and Accounts
Feb 18, 2021
Interim report
ASX
COH HY21 Result ASX & Media Release
Feb 18, 2021
Other filings
ASX
2020 AGM - Chairman and CEO & Presidents address
Oct 19, 2020
Other filings
ASX
First quarter trading update
Oct 19, 2020
Other filings
ASX
FY20 result - ASX & media release
Aug 17, 2020
Other filings
ASX
Settlement in US Patent Infringement Case
Aug 17, 2020
Other filings
ASX
Confirmation of COVID-19 pandemic impact on trading
May 10, 2020
Other filings
ASX
Cochlear Completes Share Purchase Plan
Apr 28, 2020
Financing
ASX
Cochlear Share Purchase Plan Offer Open
Mar 31, 2020
Financing
ASX
Successful completion of A$880M Institutional Placement
Mar 25, 2020
Financing
ASX
Investor Presentation
Mar 24, 2020
Other filings
ASX
Cochlear Limited announces capital raising to enhance liquid
Mar 24, 2020
Financing
ASX
Trading Halt
Mar 24, 2020
Trading halt or suspension
ASX
Adverse appeal decision in the US patent infringement case
Mar 16, 2020
Other filings
ASX
Cochlear withdraws FY20 earnings guidance due to coronavirus
Mar 15, 2020
Guidance
ASX
HY20 Result Presentation Slides
Feb 17, 2020
Other filings
ASX
HY20 Result ASX & Media Release
Feb 17, 2020
Other filings
ASX
Cochlear reduces earnings guidance due to coronavirus
Feb 10, 2020
Guidance
ASX
2019 Chairmans AGM Address to Shareholders
Oct 21, 2019
Other filings
ASX
FY19 Results ASX & Media Release
Aug 15, 2019
Other filings
ASX
COH - Profile Plus FDA Approval
Jun 16, 2019
Other filings
ASX
Cochlear announces launch of Nucleus Profile Plus implant
Apr 15, 2019
Other filings
ASX
COH Half Year Results Analyst - 19.02.2019
Feb 18, 2019
Interim report
ASX
COH Half Year Results Media Release - 19.02.2019
Feb 18, 2019
Interim report
ASX
COH - Ruling in USA Patent Infringement Case
Nov 4, 2018
Other filings
ASX
2018 Chairmans AGM Address to Shareholders
Oct 15, 2018
Other filings
ASX
Next phase development - totally implantable cochlear device
Oct 9, 2018
Other filings
ASX
COH FY18 Result Announcement
Aug 13, 2018
Other filings
ASX
Full Year Statutory Accounts - COH Appendix 4E
Aug 13, 2018
Annual report
ASX
COH announces release of Nucleus Smart App for Android
Jun 22, 2018
Other filings
ASX
COH Half Year Results Analyst Presentation
Feb 12, 2018
Interim report
ASX
COH Half Year Results Media Release 13.02.2018
Feb 12, 2018
Interim report
ASX
Half Year Accounts
Feb 12, 2018
Interim report
ASX
COH CEO Transition and Related Board Changes
Nov 13, 2017
Other filings
ASX
2017 Chairmans AGM Address to Shareholders
Oct 16, 2017
Other filings
ASX
COH FY17 Result Announcement
Aug 16, 2017
Other filings
ASX
COCHLEAR TO EXPAND GLOBAL CAPACITY
Jul 13, 2017
Other filings
ASX
Cochlear acquires audiology practice management software
May 10, 2017
Acquisition or disposal
ASX
COH Half Year Results Media Release
Feb 13, 2017
Interim report
ASX
Decision in US Patent Infringement Case
Nov 17, 2016
Other filings
ASX
2016 Chairmans AGM Address to Shareholders
Oct 17, 2016
Other filings
ASX
COH FY16 Result Announcement
Aug 8, 2016
Other filings
ASX
COH Clinic Update Letter
Mar 30, 2016
Other filings
ASX
Settlement Agreement with the DOJ and OIG
Mar 30, 2016
Other filings
ASX
Response to ASX Price Query
Mar 30, 2016
Explanation request
ASX
COH Half Year Report as at 31 December 2009 09.02.10
Mar 30, 2016
Interim report
ASX
Half Year Report and Accounts
Mar 30, 2016
Interim report
ASX
COH - F10 Preliminary Final Report - Appendix 4E
Mar 30, 2016
Results
ASX
18/10/11 Chairman`s AGM Address to Shareholders
Mar 30, 2016
Other filings
ASX
Preliminary Final Report Appendix 4E
Mar 30, 2016
Results
ASX
Half Year Report & Accounts
Feb 11, 2016
Interim report
ASX
Full Year Statutory Accounts and Annual Report
Feb 11, 2016
Annual report
ASX
COH Chris Smith Announced as Incoming CEO of Cochlear
Feb 11, 2016
Other filings
ASX
Judgment in United States Patent Infringement Lawsuit
Feb 11, 2016
Other filings
ASX
DECISION IN US PATENT INFRINGEMENT CASE
Feb 11, 2016
Other filings
ASX
COH Full Year Results Media Release 05.08.14
Feb 10, 2016
Results
ASX
Preliminary Final Report and Full Year Statutory Accounts
Feb 10, 2016
Annual report
ASX
COCHLEAR TO LAUNCH NUCLEUS PROFILE IMPLANT SERIES IN EUROP
Feb 10, 2016
Other filings
ASX
FDA approves Cochlear Nucleus Hybrid for sale in USA
Feb 10, 2016
Other filings
ASX
COH Jury Trial Verdict on USA Patent Infringement Case
Feb 10, 2016
Other filings
ASX
Hybrid Hearing Device Update
Feb 10, 2016
Other filings
ASX
15/10/13 Chairmans AGM Address to Shareholders
Feb 10, 2016
Other filings
ASX
Full Year Statutory Accounts
Feb 10, 2016
Annual report
ASX
Cochlear Limited Market Update
Feb 10, 2016
Other filings
ASX
COH Update on Nucleus CI500 series implant recall
Feb 10, 2016
Other filings
ASX
Appendix 4E and Full Year Statutory Accounts
Feb 10, 2016
Annual report
ASX
Cochlear Voluntary Recall
Feb 10, 2016
Other filings
ASX